Europe Protein Binding Assay Market Growth Opportunities and Forecast by 2028
Europe Protein Binding Assay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Equilibrium Dialysis, Ultracentrifugation, Ultrafiltration, Surface Plasmon, and Others) and End User (Contract Research Organization, Pharmaceutical & Biotechnology Companies, and Research & Diagnostic Laboratories)
- Status : Published
- Report Code : TIPRE00025440
- Category : Life Sciences
- No. of Pages : 79
- Available Report Formats :
- Last update date : October 20, 2021
2021 Market Size
US$ 100.90 Mn
Base year value
2028 Forecast
US$ 203.82 Mn
Projected by 2028
CAGR 2022-2028
10.6 %
Growth rate
Addressable Market
US$ 1,078.42 Mn
(2022-2028)
The protein binding assay market in Europe is expected to grow from US$ 100.90 million in 2021 to US$ 203.82 million by 2028; it is estimated to grow at a CAGR of 10.6% from 2021 to 2028.
The UK, Germany, and France are major economies in Europe. Growing CRO industry in emerging markets is the major factor driving the growth of the Europe protein binding assay market. Contract research organizations (CROs) have rapidly emerged as a force in drug development and clinical trial recruiting. Countries such as Italy and Spain are emerging as attractive outsourcing locations for drug manufacturers. Low manufacturing and operating costs are driving the growth of the CRO industry. The CRO industry is experiencing strong growth owing to surging technological innovations, changing regulations, and increasing outsourcing levels. There is a continuous growth in scientific base and capabilities owing to the growing contribution of clinical research, centralized healthcare institutions, well-qualified and highly motivated investigators, and excellent clinical trial facilities, which is further anticipated to drive the market in Europe.
The European economy is seriously hit due to the exponential growth of COVID-19 cases in the region. Many countries are declaring more cases each day now than during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain, and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 crises, the government of many nations is managing towards mounting up testing capacity. Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system, which is also rising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region. As of July 29, 2021, as per Worldometer, Spain, Italy, Germany, France, and the UK are among the most affected European countries. As per the data provided by Worldometer, till July 29, 2021, the UK, France, Spain, Italy, and Germany recorded 5,770,928; 6,054,049; 4,395,602; 4,330,739; and 3,769,541; respectively, COVID-19 cases and the death counts are also huge in these nations. Most of the region's sectors are massively hit by the pandemic's spread, with most nations being locked down. Number of clinical trials for the development of vaccination for the COVID-19 infection is increased thus the demand for demand for protein binding assay is also increased in this drug discovery activities.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Protein Binding Assay Market Segmentation
Europe Protein Binding Assay Market – By Technology
- Equilibrium Dialysis
- Ultracentrifugation
- Ultrafiltration
- Surface Plasmon
- Others
Europe Protein Binding Assay Market – By End User
- Contract Research Organization
- Pharmaceutical and Biotechnology Companies
- Research and Diagnostic Laboratories
Europe Protein Binding Assay Market– By Country
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
Europe Protein Binding Assay Market-Companies Mentioned
- Biotium, Inc
- Eurofins Scientific
- General Electric Company
- MERCK KGaA
- MicroConstants, Inc
- Pharmaron Beijing Co., Ltd
- Sartorius AG
- SOVICELL GMBH
- THERMO FISHER SCIENTIFIC INC.
Europe Protein Binding Assay Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 100.90 Million |
| Market Size by 2028 | US$ 203.82 Million |
| CAGR (2021 - 2028) | 10.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for